Anlon Healthcare Limited (NSE:AHCL)
India · Delayed Price · Currency is INR 25.56
+1.21 (4.97%)
At close: Oct 23, 2026
Anlon Healthcare Revenue
Anlon Healthcare had revenue of 875.63M INR in the quarter ending June 30, 2026, with 162.97% growth. This brings the company's total for the last twelve months to 2.26B, up 95.37% year-over-year. In the fiscal year ending March 31, 2026, Anlon Healthcare had annual revenue of 1.72B with 42.95% growth. That makes Anlon Healthcare the 32,758th largest company in the world by revenue and 2,416th in India.
Revenue (ttm)
2.26B
Revenue Growth
+95.37%
P/S Ratio
5.72
Revenue / Employee
19.01M
Employees
119
Market Cap
13.59B
Revenue by Geography
- India 1.69B 98.0%
- Export 34.59M 2.0%
Fiscal year ended Mar 31, 2026 See the full Anlon Healthcare breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.72B | 516.78M | 42.95% |
| Mar 31, 2025 | 1.20B | 537.17M | 80.64% |
| Mar 31, 2024 | 666.16M | -464.64M | -41.09% |
| Mar 31, 2023 | 1.13B | 556.91M | 97.04% |
| Mar 31, 2022 | 573.89M | 414.09M | 259.14% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Indoco Remedies | 18.73B |
| Solara Active Pharma Sciences | 15.35B |
| Windlas Biotech | 9.42B |
| Ind-Swift Laboratories | 6.74B |
| Sigachi Industries | 4.71B |
| Beta Drugs | 4.10B |
| Valiant Laboratories | 3.06B |
| Jagsonpal Pharmaceuticals | 2.94B |